Cargando…

Decreased protein binding of moxifloxacin in patients with sepsis?

The mean (SD) unbound fraction of moxifloxacin in plasma from patients with severe sepsis or septic shock was determined by ultrafiltration to 85.5±3.0% (range 81.9 and 91.6%) indicating a decreased protein binding of moxifloxacin in this population compared with the value of 58–60% provided in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorn, Christoph, Nowak, Hartmuth, Weidemann, Caroline, Martini, Stefan, Zeitlinger, Markus, Adamzik, Michael, Kees, Frieder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: German Medical Science GMS Publishing House 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301732/
https://www.ncbi.nlm.nih.gov/pubmed/30671325
http://dx.doi.org/10.3205/id000029
_version_ 1783381853548314624
author Dorn, Christoph
Nowak, Hartmuth
Weidemann, Caroline
Martini, Stefan
Zeitlinger, Markus
Adamzik, Michael
Kees, Frieder
author_facet Dorn, Christoph
Nowak, Hartmuth
Weidemann, Caroline
Martini, Stefan
Zeitlinger, Markus
Adamzik, Michael
Kees, Frieder
author_sort Dorn, Christoph
collection PubMed
description The mean (SD) unbound fraction of moxifloxacin in plasma from patients with severe sepsis or septic shock was determined by ultrafiltration to 85.5±3.0% (range 81.9 and 91.6%) indicating a decreased protein binding of moxifloxacin in this population compared with the value of 58–60% provided in the Summary of Product Characteristics. However, previous investigations neglected the influence of pH and temperature on the protein binding of moxifloxacin. Maintaining physiological conditions (pH 7.4, 37°C) – as in the present study – the unbound fraction of moxifloxacin in plasma from healthy volunteers was 84%. In contrast, the unbound fraction of moxifloxacin was 77% at 4°C and 66–68% in unbuffered plasma or at pH 8.5 in fair agreement with previously published data. PK/PD parameters e.g. fAUC/MIC or ratios between interstitial fluid and free plasma concentrations, which were obtained assuming a protein binding rate of moxifloxacin of 40% or more, should be revised.
format Online
Article
Text
id pubmed-6301732
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher German Medical Science GMS Publishing House
record_format MEDLINE/PubMed
spelling pubmed-63017322019-01-22 Decreased protein binding of moxifloxacin in patients with sepsis? Dorn, Christoph Nowak, Hartmuth Weidemann, Caroline Martini, Stefan Zeitlinger, Markus Adamzik, Michael Kees, Frieder GMS Infect Dis Article The mean (SD) unbound fraction of moxifloxacin in plasma from patients with severe sepsis or septic shock was determined by ultrafiltration to 85.5±3.0% (range 81.9 and 91.6%) indicating a decreased protein binding of moxifloxacin in this population compared with the value of 58–60% provided in the Summary of Product Characteristics. However, previous investigations neglected the influence of pH and temperature on the protein binding of moxifloxacin. Maintaining physiological conditions (pH 7.4, 37°C) – as in the present study – the unbound fraction of moxifloxacin in plasma from healthy volunteers was 84%. In contrast, the unbound fraction of moxifloxacin was 77% at 4°C and 66–68% in unbuffered plasma or at pH 8.5 in fair agreement with previously published data. PK/PD parameters e.g. fAUC/MIC or ratios between interstitial fluid and free plasma concentrations, which were obtained assuming a protein binding rate of moxifloxacin of 40% or more, should be revised. German Medical Science GMS Publishing House 2017-02-03 /pmc/articles/PMC6301732/ /pubmed/30671325 http://dx.doi.org/10.3205/id000029 Text en Copyright © 2017 Dorn et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Dorn, Christoph
Nowak, Hartmuth
Weidemann, Caroline
Martini, Stefan
Zeitlinger, Markus
Adamzik, Michael
Kees, Frieder
Decreased protein binding of moxifloxacin in patients with sepsis?
title Decreased protein binding of moxifloxacin in patients with sepsis?
title_full Decreased protein binding of moxifloxacin in patients with sepsis?
title_fullStr Decreased protein binding of moxifloxacin in patients with sepsis?
title_full_unstemmed Decreased protein binding of moxifloxacin in patients with sepsis?
title_short Decreased protein binding of moxifloxacin in patients with sepsis?
title_sort decreased protein binding of moxifloxacin in patients with sepsis?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301732/
https://www.ncbi.nlm.nih.gov/pubmed/30671325
http://dx.doi.org/10.3205/id000029
work_keys_str_mv AT dornchristoph decreasedproteinbindingofmoxifloxacininpatientswithsepsis
AT nowakhartmuth decreasedproteinbindingofmoxifloxacininpatientswithsepsis
AT weidemanncaroline decreasedproteinbindingofmoxifloxacininpatientswithsepsis
AT martinistefan decreasedproteinbindingofmoxifloxacininpatientswithsepsis
AT zeitlingermarkus decreasedproteinbindingofmoxifloxacininpatientswithsepsis
AT adamzikmichael decreasedproteinbindingofmoxifloxacininpatientswithsepsis
AT keesfrieder decreasedproteinbindingofmoxifloxacininpatientswithsepsis